Atypical femur fracture in a male without history of bisphosphonate use: a case report

被引:0
|
作者
Al-Ajlouni, Yazan A. [1 ]
Lee, Justin Lin [1 ]
Lee, Jessica Lin [1 ]
Samuels, Blossom [1 ,2 ]
机构
[1] New York Med Coll, Sch Med, Valhalla, NY 10595 USA
[2] Westchester Med Ctr, Valhalla, NY 10595 USA
关键词
Atypical femur fractures; Bisphosphonate-naive; Male; Teriparatide; Surgical management; FEMORAL FRACTURES; TERIPARATIDE; RISK;
D O I
10.1186/s13256-023-04308-y
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BackgroundAtypical femur fractures are a rare occurrence, especially in bisphosphonate-naive men, and merit reporting owing to their unusual presentation and clinical implications. This case report highlights a unique instance of atypical femur fractures in a 73-year-old male with no prior bisphosphonate exposure.Case presentationThe patient, a 73-year-old Indian male with no history of bisphosphonate use, presented with left thigh pain and swelling following a minor fall. Radiographic assessment unveiled a closed left mid diaphyseal femoral shaft fracture. Subsequent imaging revealed an impending fracture in the contralateral femur. A comprehensive diagnostic evaluation, encompassing radiographic analysis, laboratory tests, and clinical assessment confirmed the diagnosis. Surgical management via intramedullary nailing was pursued for both fractures. Notably, the patient's medical history was characterized by radiographic manifestations, the infrequent occurrence of atypical femur fractures in men, and associated risk factors. Treatment encompassed anabolic bone therapy employing teriparatide, alongside discontinuation of antiresorptive agents.ConclusionsThis case underscores the significance of considering atypical femur fractures in older individuals with limited trauma history. It accentuates the role of anabolic agents in the therapeutic regimen and contributes to the evolving understanding of atypical femur fractures. The report underscores the need for vigilant monitoring and tailored management strategies in similar cases, thereby enhancing clinical practice and patient care.
引用
收藏
页数:5
相关论文
共 50 条
  • [21] Treatment of Bisphosphonate-Associated Atypical Femur Fracture With a Combination of Teriparatide and a Novel Surgical Technique
    Chincholi, Aditi H.
    Cooper, Anna R.
    Mullally, Jamie A.
    AACE CLINICAL CASE REPORTS, 2024, 10 (05): : 170 - 173
  • [22] Different surgical outcomes in a patient with bilateral atypical femoral fracture related to bisphosphonate use with or without teriparatide treatment
    H.-y. Zhang
    H.-l. Weng
    M. Li
    J. Zhang
    Osteoporosis International, 2019, 30 : 2349 - 2354
  • [23] Bilateral atypical femur fracture in a patient with breast cancer taking zoledronic acid and denosumab: A case report
    Hashimoto, Kazuhiko
    Ito, Tomohiko
    Yamagishi, Yuto
    Goto, Koji
    MODERN RHEUMATOLOGY CASE REPORTS, 2024, : 41 - 45
  • [24] Successful teriparatide treatment of atypical fracture after long-term use of alendronate without surgical procedure in a postmenopausal woman: a case report
    Huang, Hsuan-Ti
    Kang, Lin
    Huang, Peng-Ju
    Fu, Yin-Chih
    Lin, Sung-Yen
    Hsieh, Chih-Hsin
    Chen, Jian-Chih
    Cheng, Yuh-Min
    Chen, Chung-Hwan
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2012, 19 (12): : 1360 - 1363
  • [25] Risk of complete atypical femur fracture with Oral bisphosphonate exposure beyond three years
    Lo, Joan C.
    Neugebauer, Romain S.
    Ettinger, Bruce
    Chandra, Malini
    Hui, Rita L.
    Ott, Susan M.
    Grimsrud, Christopher D.
    Izano, Monika A.
    BMC MUSCULOSKELETAL DISORDERS, 2020, 21 (01)
  • [26] Atypical fractures of the femur and bisphosphonate therapy A systematic review of case/case series studies
    Giusti, Andrea
    Hamdy, Neveen A. T.
    Papapoulos, Socrates E.
    BONE, 2010, 47 (02) : 169 - 180
  • [27] Case report Femur fracture in an infant
    Radesky, Jenny S.
    Sugar, Naomi F.
    BMJ-BRITISH MEDICAL JOURNAL, 2009, 338 : 1217+1175
  • [28] Surgical outcome of atypical subtrochanteric and femoral fracture related to bisphosphonates use in osteoporotic patients with or without teriparatide treatment
    Yeh, Wen-Ling
    Su, Chun-Yi
    Chang, Chia-Wei
    Chen, Chien-Hao
    Fu, Tsai-Sheng
    Chen, Lih-Huei
    Lin, Tung-Yi
    BMC MUSCULOSKELETAL DISORDERS, 2017, 18
  • [29] Bisphosphonate-related Atypical Femoral Fracture with Bone Metastasis of Breast Cancer: Case Report and Review
    Hayashi, Kazunori
    Aono, Masanari
    Shintani, Kousuke
    Kazuki, Kenichi
    ANTICANCER RESEARCH, 2014, 34 (03) : 1245 - 1249
  • [30] Healing Time and Complications in Operatively Treated Atypical Femur Fractures Associated With Bisphosphonate Use: A Multicenter Retrospective Cohort
    Bogdan, Yelena
    Tornetta, Paul, III
    Einhorn, Thomas A.
    Guy, Pierre
    Leveille, Lise
    Robinson, Juan
    Bosse, Michael J.
    Haines, Nikkole
    Horwitz, Daniel
    Jones, Clifford
    Schemitsch, Emil
    Sagi, Claude
    Thomas, Bryan
    Stahl, Daniel
    Ricci, William
    Brady, Megan
    Sanders, David
    Kain, Michael
    Higgins, Thomas F.
    Collinge, Cory
    Kottmeier, Stephen
    Friess, Darin
    JOURNAL OF ORTHOPAEDIC TRAUMA, 2016, 30 (04) : 177 - 181